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The antioxidant enzymes (as superoxide dismutase /SOD/ and catalase /CAT/) are significant potential agents 
for therapeutic aim but they demanded the improvement of their biopharmaceutical properties. For this goal the 
bienzyme covalent conjugate was obtained by binding SOD with CAT via endothelial glycocalyx 
glycosaminoglycan – chondroitin sulfate (SOD-CHS-CAT). The SOD-CHS-CAT conjugate had preventive 
actions after intravenous administration of hydrogen peroxide in rabbits and rats. It should be noted the 
oxidative stress accompanies for development of endotoxin shock. There is the model of septic shock of 
animals due to administration of bacterial lypopolysaccharide (LPS, from Salmonella enterica serotype 
Typhimurium) them as provoking infectious agent. The therapeutic effect of bienzyme SOD-CHS-CAT conjugate 
has special research interest associated with activity of conjugate after preventive and medicative administration 
(i.e. before and after LPS administration, respectively). The effect of bienzyme conjugate administered in 
medicative regime had increased the survival of rats for endotoxin shock. It was the expressive efficacy of 
medicinal employment of SOD-CHS-CAT conjugate. The obtained results have been grounded the need of 
experimental evaluation in respect to efficacy of per oral prophylaxis administration of SOD-CHS-CAT conjugate 
on the endotoxin model injury in rats induced by LPS bolus. The intravenous bolus administration of LPS in rats 
has been induced the endotoxin shock development with arterial pressure (AP) decrease, heart rate (HR) 
increase, impairment of condition even before the lethal termination. The AP decrease was restored faster in 
experimental group; the alterations of HR were similar in both groups. The survival index (73 % in experimental 
and 63 % in control groups) for twenty-four hours was similar. Higher survival index (95 % in experimental and 
75 % in control groups, for five hours) was marked in experimental group emphasizing the action celerity of 
SOD-CHS-CAT conjugate in vivo.  The SOD-CHS-CAT conjugate was active during cytokine phase of 
endotoxin injury and distant damage stages. Moreover, the level of NO in lever, lung, kidney, heart was 
enhanced during endotoxin shock progress and there were not significant alterations of NO level after bienzyme 
conjugate administration intravenously. The changes of urea and creatinine in blood samples have been 
evidenced the protective action of bienzyme conjugate in respect to kidney function. Diversity of other index 
alterations have been hampered the forming agreed conclusions about state of other organs. Taken together 
these date indicated (on the base of survival increase of rats with SOD-CHS-CAT conjugate for endotoxin 
shock) the other protective effects of this conjugate (besides NO preservation) and importance of its action 
mechanism investigation on animal model with continuous development of injury and involvement of other 
vasoactive agents (NO-independent progress of therapeutic effect).   This research was supported in part by 
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